Latest Industry Insights
Industry Insight
How AI Is Accelerating the Digital Transformation of Pathology
Technology Networks spoke with Dr. Olga Colgan and Dr. Joseph Chiweshe to learn how AI-driven digital pathology is reshaping diagnostic workflows.
Industry Insight
Circular RNA: The Next Frontier for RNA Therapeutics?
Discover how circular RNA and targeted delivery technologies are advancing RNA therapeutics for chronic diseases and vaccines.
Industry Insight
How Biotech Startups Are Redefining 3D Models and Sustainability in Drug Discovery
Explore how biotech start-ups are using 3D models and automation to reduce animal testing, cut waste and improve drug discovery outcomes.
Industry Insight
Can Patients Trust a Drug Designed By AI?
Patient trust is vital as AI transforms pharma and drug discovery. Discover how transparency and regulation are making innovation safer.
Industry Insight
How Crowdfunding Could Change the Cell and Gene Therapy Investor Landscape
Discover how crowdfunding could help biotech startups and cell and gene therapy developers overcome funding barriers by engaging patients, physicians and everyday investors.
Industry Insight
Improving the Accessibility of AAV Quantification in Gene Therapy Development
Learn how the Amperia platform improves AAV quantification accuracy and speed, making gene therapy development more accessible and consistent.
Industry Insight
Overcoming Toxicity Challenges in Gene Therapy
Explore the dosing challenges posed by current gene therapies and how circular RNA may unlock more potent and safer therapies.
Industry Insight
Genomics Testing Needs Structured Data To Succeed
Dr. Heidi Rehm shares insights on how genomics is evolving at the intersection of research and clinical practice. In this Q&A, she highlights the role of AI, global data standards and collaboration in shaping future patient care.
Industry Insight
Building Infinity™: How GeneDx Is Transforming Rare Disease Diagnosis
Families with rare diseases often wait years for answers. GeneDx’s AI-driven dataset, Infinity™, is changing that. In this interview, Dr. Bryan Dechario explains how decades of data are reshaping the future of genomic medicine.
Industry Insight
Advances in Deep Visual Proteomics With Dr. Andreas Mund
Deep Visual Proteomics integrates high-resolution imaging, AI and ultra-sensitive mass spectrometry to map proteins at single-cell resolution while preserving spatial context.
Advertisement